Colorcon acquires Paulaur Corporation, a manufacturer of specialty sugar-based ingredients.
Colorcon announced on Jan. 18, 2016 the acquisition of the Pharmaceutical Sugar Spheres product line from Paulaur Corporation, a manufacturer of specialty sugar-based ingredients located in Cranbury, New Jersey.
The addition of the Paulaur products complements Colorcon’s Suglets Sugar Spheres product line. The agreement is specific to Paulaur sugar spheres sold into the pharmaceutical and nutritional segments globally. Colorcon provides speciality excipients for pharmaceutical and nutraceutical applications worldwide and has identified strong synergies between the multiparticulate and film-coating businesses.
“Paulaur had made the decision to leave the pharmaceutical and nutraceutical spheres arena in order to concentrate on our fast-growing food and confectionary business,” said Mitchell Stefaniak, vice-president and chief financial officer of Paulaur Corporation. “At the same time, we wanted to ensure that our pharmaceutical and nutraceutical spheres customers could be assured of a continued availability of quality product. The sale to Colorcon provides our customers with just such a supplier.”
Colorcon provides products and services for solid oral-dosage formulations. As a result of this agreement, Colorcon and Paulaur customers stand to benefit with direct access to products, technical service, and support from Colorcon.
Source: Colorcon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.